These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 1705993)
1. Equine infectious anemia virus and human immunodeficiency virus DNA synthesis in vitro: characterization of the endogenous reverse transcriptase reaction. Borroto-Esoda K; Boone LR J Virol; 1991 Apr; 65(4):1952-9. PubMed ID: 1705993 [TBL] [Abstract][Full Text] [Related]
2. Initiation of (-) strand DNA synthesis from tRNA(3Lys) on lentiviral RNAs: implications of specific HIV-1 RNA-tRNA(3Lys) interactions inhibiting primer utilization by retroviral reverse transcriptases. Arts EJ; Stetor SR; Li X; Rausch JW; Howard KJ; Ehresmann B; North TW; Wöhrl BM; Goody RS; Wainberg MA; Grice SF Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10063-8. PubMed ID: 8816751 [TBL] [Abstract][Full Text] [Related]
4. Fidelity of DNA synthesis exhibited in vitro by the reverse transcriptase of the lentivirus equine infectious anemia virus. Bakhanashvili M; Hizi A Biochemistry; 1993 Jul; 32(29):7559-67. PubMed ID: 7687876 [TBL] [Abstract][Full Text] [Related]
5. Incorporation of uracil into viral DNA correlates with reduced replication of EIAV in macrophages. Steagall WK; Robek MD; Perry ST; Fuller FJ; Payne SL Virology; 1995 Jul; 210(2):302-13. PubMed ID: 7542416 [TBL] [Abstract][Full Text] [Related]
6. Expression and mutational analysis of the reverse transcriptase of the lentivirus equine infectious anemia virus. Shaharabany M; Rice NR; Hizi A Biochem Biophys Res Commun; 1993 Oct; 196(2):914-20. PubMed ID: 7694581 [TBL] [Abstract][Full Text] [Related]
7. Truncation of the Cytoplasmic Tail of Equine Infectious Anemia Virus Increases Virion Production by Improving Env Cleavage and Plasma Membrane Localization. Wang XF; Wang YH; Bai B; Zhang M; Chen J; Zhang X; Gao M; Wang X J Virol; 2021 Nov; 95(23):e0108721. PubMed ID: 34495693 [TBL] [Abstract][Full Text] [Related]
8. Replication in vitro and in vivo of an equine infectious anemia virus mutant deficient in dUTPase activity. Lichtenstein DL; Rushlow KE; Cook RF; Raabe ML; Swardson CJ; Kociba GJ; Issel CJ; Montelaro RC J Virol; 1995 May; 69(5):2881-8. PubMed ID: 7707512 [TBL] [Abstract][Full Text] [Related]
9. Characterization of (+) strand initiation and termination sequences located at the center of the equine infectious anemia virus genome. Stetor SR; Rausch JW; Guo MJ; Burnham JP; Boone LR; Waring MJ; Le Grice SF Biochemistry; 1999 Mar; 38(12):3656-67. PubMed ID: 10090753 [TBL] [Abstract][Full Text] [Related]
10. Equine Myxovirus Resistance Protein 2 Restricts Lentiviral Replication by Blocking Nuclear Uptake of Capsid Protein. Ji S; Na L; Ren H; Wang Y; Wang X J Virol; 2018 Sep; 92(18):. PubMed ID: 29743377 [TBL] [Abstract][Full Text] [Related]
11. RNA-dependent DNA polymerase associated with equine infectious anemia virus. Archer BG; Crawford TB; McGuire TC; Frazier ME J Virol; 1977 Apr; 22(1):16-22. PubMed ID: 67219 [TBL] [Abstract][Full Text] [Related]
12. Purification and kinetic characterization of equine infectious anemia virus reverse transcriptase. Thomas DA; Furman PA Biochem Biophys Res Commun; 1991 Nov; 180(3):1365-71. PubMed ID: 1719980 [TBL] [Abstract][Full Text] [Related]
13. Proviral DNA integration and transcriptional patterns of equine infectious anemia virus during persistent and cytopathic infections. Rasty S; Dhruva BR; Schiltz RL; Shih DS; Issel CJ; Montelaro RC J Virol; 1990 Jan; 64(1):86-95. PubMed ID: 2152836 [TBL] [Abstract][Full Text] [Related]
14. Characterization of equine infectious anemia virus dUTPase: growth properties of a dUTPase-deficient mutant. Threadgill DS; Steagall WK; Flaherty MT; Fuller FJ; Perry ST; Rushlow KE; Le Grice SF; Payne SL J Virol; 1993 May; 67(5):2592-600. PubMed ID: 8386267 [TBL] [Abstract][Full Text] [Related]
15. Equine infectious anemia virus resists the antiretroviral activity of equine APOBEC3 proteins through a packaging-independent mechanism. Bogerd HP; Tallmadge RL; Oaks JL; Carpenter S; Cullen BR J Virol; 2008 Dec; 82(23):11889-901. PubMed ID: 18818324 [TBL] [Abstract][Full Text] [Related]
16. Sequences in the 5' and 3' R elements of human immunodeficiency virus type 1 critical for efficient reverse transcription. Ohi Y; Clever JL J Virol; 2000 Sep; 74(18):8324-34. PubMed ID: 10954531 [TBL] [Abstract][Full Text] [Related]
17. Effects of zidovudine-selected human immunodeficiency virus type 1 reverse transcriptase amino acid substitutions on processive DNA synthesis and viral replication. Caliendo AM; Savara A; An D; DeVore K; Kaplan JC; D'Aquila RT J Virol; 1996 Apr; 70(4):2146-53. PubMed ID: 8642636 [TBL] [Abstract][Full Text] [Related]
18. Viral DNA carried by human immunodeficiency virus type 1 virions. Lori F; di Marzo Veronese F; de Vico AL; Lusso P; Reitz MS; Gallo RC J Virol; 1992 Aug; 66(8):5067-74. PubMed ID: 1378514 [TBL] [Abstract][Full Text] [Related]
19. Effects of long terminal repeat sequence variation on equine infectious anemia virus replication in vitro and in vivo. Lichtenstein DL; Craigo JK; Leroux C; Rushlow KE; Cook RF; Cook SJ; Issel CJ; Montelaro RC Virology; 1999 Oct; 263(2):408-17. PubMed ID: 10544113 [TBL] [Abstract][Full Text] [Related]
20. Tissue sites of persistent infection and active replication of equine infectious anemia virus during acute disease and asymptomatic infection in experimentally infected equids. Harrold SM; Cook SJ; Cook RF; Rushlow KE; Issel CJ; Montelaro RC J Virol; 2000 Apr; 74(7):3112-21. PubMed ID: 10708426 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]